More than $1 billion is being spent annually to market these drugs and why not, when the manufacturers charge up to $16,000 per year per consumer
Dawkins and Pratley note that while studies show people with obesity and type 2 diabetes experience significant weight loss on a GLP-1 agonist or dual agonist, people with type 2 diabetes experience slightly less weight loss compared with those with overweight and obesity without type 2 diabetes.1-3 Counseling Tips for RDs Despite the success of these classes of weight management medications, patients can receive anywhere from a little to a lot of information on how to optimize their use since a wide variety of clinicians, from primary care providers to obesity medicine experts, prescribe them
Most community protocols wait longer than that - typically 8 weeks of tirzepatide alone before adding cagrilintide
Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S et al (2013)
In June, 21 plaintiffs petitioned for a Multicounty Litigation (MCL) in New Jersey state court specific to NAION-related injuries, suggesting a potential expansion in the scope of the litigation and new challenges in causation and medical proof
